HOUSTON, Texas — Sharps Compliance Corp., a provider of cost-effective disposal solutions for small quantity generators of medical waste, today launched a larger version of its flagship product, the Sharps Disposal By Mail System(R), specifically designed to meet the needs of medical professionals, such as physician and dental offices, and provide a safe and efficient alternative to traditional, more costly medical waste pick-up services.
In addition to the convenient and safe disposal of used syringes, the new 18-gallon Medical Professional Sharps Disposal By Mail System(R) can be used to collect all of the medical waste including red bag (biohazard) waste as well as existing sharps containers located in each examination room. The product is permitted by the United States Postal System for transport to the Sharps' owned medical waste disposal facility located in Carthage, Texas. The mail-back solution is a cost-effective and flexible solution.
Dr. Burton J. Kunik, the company's chairman, CEO and president commented, "With approximately 850,000 practicing physicians, dentists and veterinarians located across the country, we believe the market opportunity for the Medical Professional Sharps Disposal By Mail System(R) could exceed $350 million annually. We developed the new product offering based on feedback from the medical community as a comprehensive solution to reduce the cost of medical waste disposal outside of the hospital setting. Additional revenue opportunities exist for this new line of products in clinics, schools and similar settings. We have begun to market the new product through our direct sales force and network of distributors. As a leader in the industry, we are committed to listening to our customers and providing products to meet their unique needs, which ultimately contributes to our sales pipeline and billings growth in fiscal 2009 and beyond."
Source: Sharps Compliance Corp.
Outbreak Detection, Patient Protection: The Legal Upside of Genomics in Infection Prevention
May 21st 2025A string of infections following routine knee surgeries in Tennessee has escalated into litigation, raising questions about how—and when—health care facilities should detect outbreaks. As genomic surveillance gains traction in infection prevention, some fear it could increase legal risk. In reality, it may offer hospitals their strongest legal defense.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Outbreak Detection, Patient Protection: The Legal Upside of Genomics in Infection Prevention
May 21st 2025A string of infections following routine knee surgeries in Tennessee has escalated into litigation, raising questions about how—and when—health care facilities should detect outbreaks. As genomic surveillance gains traction in infection prevention, some fear it could increase legal risk. In reality, it may offer hospitals their strongest legal defense.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
2 Commerce Drive
Cranbury, NJ 08512